Svenska
Boston
An independent LDT provider
Home
About us
Home
About us
Learn more
Vision and mission
Leadership
About us
Leadership
Learn more
Board of directors
Management team
Medical Advisory Board
Collaborations
About us
Collaborations
Learn more
Patient Advocacy Support
Immunovia, Inc.
Immunovia Dx Laboratory, Lund
Company history
Sustainability
About us
Sustainability
Learn more
Sustainability report
Code of conduct
Work environment
Diversity
Calendar
Careers
IMMray™ Platform
Home
IMMray™ Platform
Learn more
Technology
Production
Pancreatic Cancer
IMMray™ Platform
Pancreatic Cancer
Learn more
Pancreatic cancer high risk groups
Clinical performance
Clinical prospective study program
Current technologies for detection and diagnosis
Pipeline
IMMray™ Platform
Pipeline
Learn more
Lung cancer
Investors
Media
Home
Media
Learn more
Press releases
Presentations
Webinars
Tutorials
Videos
Audio
Publications
Social media
Media resources
Partnering
Contact Us
Subscribe
Immunovia Inc
English
Svenska
Press releases
Show
All
Regulatory
R = Regulatory
April 22, 2021
Immunovia reiterates its road to reimbursement for the IMMray™...
April 21, 2021
Immunovia presents update on US market size for IMMray™ PanCan-d in ...
April 21, 2021
Invitation to Presentation of Immunovia’s Interim Report January...
April 16, 2021
IMMray™ PanCan-d highlighted in meeting arranged by Pancreatic...
March 31, 2021
KALLELSE TILL ÅRSSTÄMMA I IMMUNOVIA AB
March 29, 2021
Immunovia reports positive results of the blinded clinical validation ...
March 29, 2021
Immunovia reports improved test performance of IMMray[TM] PanCan-d in ...
March 12, 2021
Immunovia publishes the annual report for the financial year 2020
February 26, 2021
Immunovia publishes data sets on the Optimization Study and...
February 17, 2021
Immunovia Full Year Report 2020
R
February 15, 2021
Immunovia’s PanFAM-1 Prospective Study Gathers Over 3000 Familial...
February 11, 2021
Invitation to presentation of Immunovia’s Full Year Report 2020 on...
<
1
2
3
4
5
…
21
>
Home
Press releases
Page 3
